We are an independent, global, inter-disciplinary, non-partisan group of policy-makers, scholars, scientists, strategists and others convened to think through the wide range of issues and crises associated with the Covid-19 pandemic. The Commission’s purpose is to enable informed discourse and decision-making, to frame priorities and help build consensus on policy solutions to strengthen societal and global resilience. The full list of Commissioners can be found here.





If the current daily vaccination rate of 37 million doses could be maintained, the world could achieve full vaccination of 80% of adults in the time shown on the clock. This is far sooner than most people realise. Herd immunity could be achieved between December 2021 and May 2022, depending on whether other countries can match China. This won’t be easy. In just the past week, however, 33 days have been cut from the countdown date for the world ex-China, thanks to rising vaccination rates.

* Seven-day rolling average. Source: Our World In Data

After the G7’s vaccine pledges, China will take the lead


By Bill Emmott, Co-Director, GCPPP, June 11th 2021

That is great for the world, but ought to be less cheering for the West if the goal of the Group of Seven’s pledges is one of re-establishing western leadership or even equality.

Following the promises made by the G7 countries at their summit in Cornwall to donate one billion COVID vaccines to poor countries, we now know the big pandemic news of 2022. This is that the world will have been vaccinated far sooner than most now expect, chiefly thanks to Chinese donations and sales of vaccines, with some belated but welcome help from the West. Well done, China.

Close shot of a vaccine being drawn from a vial into a syringe. The word COVID-19 floats in the background.

What we know about vaccine hesitancy

By Dylan Barry, GCPPP staff, June 10th 2021

As vaccination programmes reach high proportions of populations in advanced countries, the key question is how much of a threat resistance to vaccination may pose to hopes of achieving the herd immunity scientists say is needed to suppress the virus’s transmission. In this analysis, we look at what opinion polls have revealed about initial levels of vaccine hesitancy and at how that resistance is evolving as time passes and evidence of vaccines efficacy and safety spread.

Bar reopening in New York

The Pandemic This Week

Our summary of the main pandemic crises-related news in the week to June 18th.

Visualisation of COVID-19 virus


By Luke Lythgoe, GCPPP Staff, June 1st 2021

This Research Monitor explores what we know about the key variants discovered so far, and what risks they pose.

Leading Indicators

Our second monthly update on the world’s progress in producing vaccines to protect against COVID-19 shows a welcome near doubling of output in May, to 822 million doses, thanks to a trebling in output by Chinese firms and substantial increases in the EU and US too.